Taysha Gene Therapies, Inc. (TSHA) Earnings
NASDAQ·Healthcare·Biotechnology
$5.76
+3.14%
Mkt Cap $1.35B
EPS — Estimate vs Actual
Mkt Cap
$1.35B
P/E
—
Fwd P/E
—
P/S
180.86
Rev TTM
—
EPS TTM
-$0.38
NASDAQ·Healthcare·Biotechnology
$5.76
+3.14%
Mkt Cap $1.35B
Mkt Cap
$1.35B
P/E
—
Fwd P/E
—
P/S
180.86
Rev TTM
—
EPS TTM
-$0.38